PRESIDENT AND FELLOWS OF HARVARD COLLEGE;EMORY UNIVERSITY;DANA-FARBER CANCER INSTITUTE INC.
发明人:
申请号：
IL25163717
公开号：
IL251637A
申请日:
2017.04.06
申请国别(地区):
IL
年份:
2019
代理人:
摘要：
PD-1 antagonists are disclosed that can be used to reduce the expression or activity of PD-1 in a subject. An immune response specific to an infectious agent or to tumor cells can be enhanced using these PD-1 antagonists in conjunction with an antigen from the infectious agent or tumor. Thus, subj ects with infections, such as persistent infections can be treated using PD-1 antagonists. In additions, subjects with tumors can be treated using the PD-1 antagonists. In several examples, subjects can be treated by transplanting a therapeutically effective amount of activated T cells that recognize an antigen of interest and by administering a therapeutically effective amount of a PD-1 antagonist.
